6-Bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylic acid

Introduction

CAS No. :	1260784-00-6	MDL No. :	MFCD13193299
Formula :	C8H4BrFN2O2	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	NZKZILYLERQVJY-UHFFFAOYSA-N
M.W :	259.03	Pubchem ID :	71748415
Synonyms :

Physicochemical Properties

Num. heavy atoms :	14
Num. arom. heavy atoms :	9
Fraction Csp3 :	0.0
Num. rotatable bonds :	1
Num. H-bond acceptors :	4.0
Num. H-bond donors :	1.0
Molar Refractivity :	49.81
TPSA :	54.6 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.17 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.4
Log Po/w (XLOGP3) :	2.41
Log Po/w (WLOGP) :	2.35
Log Po/w (MLOGP) :	1.47
Log Po/w (SILICOS-IT) :	1.38
Consensus Log Po/w :	1.8

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.56

Water Solubility

Log S (ESOL) :	-3.37
Solubility :	0.109 mg/ml ; 0.000423 mol/l
Class :	Soluble
Log S (Ali) :	-3.2
Solubility :	0.164 mg/ml ; 0.000633 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-2.59
Solubility :	0.66 mg/ml ; 0.00255 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	1.93

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine